Google
Apple
English (UK)
English (Canada)
Deutsch (Deutschland)
Deutsch (Schweiz)
Español
Français (France)
Italiano
Nederlands (Nederland)
Nederlands (België)
GRIFOLS, S.A. |
Market Closed -
Other stock markets
|
|
After market 12:44:04 pm | ||
| 13.3 EUR | +0.68% | 13.23 | -0.53% | |
| 04:52pm | JPMorgan Adjusts Grifols' Price Target to $10.50 From $10, Maintains Neutral Rating | MT |
| Nov. 30 | Italy, Spain stocks hit peaks after over 20% rally in 2023 | RE |
Presenter SpeechNuria Lapeña (Executives)Hello, everyone, and welcome to Grifols' Full Year 2022 Conference Call. ...
This article is reserved for subscribers To unlock the article, SUBSCRIBE!
Already a customer? Log In
Grifols, S.A. specializes in the research, development, manufacturing and marketing of therapeutic products and medical devices for use in hospitals and medical analysis laboratories. Net sales break down by family of products and services as follows:
- products derived from plasma (77.3%): products for use by the pharmaceutical and biotechnology industries;
- diagnostic machines and reagents (14.9%): in vitro hemophilic diagnostic equipment, coagulation analyzers, infectious serology reagents, etc. for use primarily by blood banks and transfusion centers;
- hospital products (2.4%): non-biological surgical products, radiology and nutritional products, etc. for use by hospital pharmacies;
- other (5.4%): primarily intermediate biological products and subcontracted manufacturing services.
Net sales are distributed geographically as follows: Spain (5.3%), European Union (11.7%), the United States and Canada (63.6%) and other (19.4%).
Sector
Pharmaceuticals
Calendar
2024-02-28
- Q4 2023 Earnings Release (Projected)
Trading Rating :
Investor Rating :
ESG Refinitiv :
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
17
Last Close Price
13.21EUR
Average target price
18.54EUR
Spread / Average Target
+40.36%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +23.49% | 8 555 M $ | |
| -8.56% | 84 465 M $ | |
| -12.91% | 38 718 M $ | |
| -16.91% | 33 740 M $ | |
| +8.21% | 21 257 M $ | |
| -49.29% | 18 046 M $ | |
| -8.78% | 17 782 M $ | |
| -0.65% | 15 316 M $ | |
| -31.47% | 12 317 M $ | |
| +24.18% | 8 738 M $ |
- Stock
- Equities
- Stock Grifols, S.A. - Bolsas y Mercados Espanoles
- News Grifols, S.A.
- Transcript : Grifols, S.A., 2022 Earnings Call, Feb 28, 2023
